PCM
CDNA icon

Penserra Capital Management’s CareDx CDNA Stock Holding History

Penserra Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-88,358
Closed -$8.09M – 1460
2021
Q2 		$8.09M Buy
+88,358
New +$7.02M 0.15% 188

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Penserra Capital Management's CDNA Position: Q3 2021 in Review

Penserra Capital Management sold out of CareDx (CDNA) in Q3 2021, closing a stake of 88,358 shares — an estimated $8.09M sold.

Penserra Capital Management first reported a position in CDNA in Q2 2021 and held it in 1 quarter. The position peaked at $8.09M in Q2 2021. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Penserra Capital Management reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • Penserra Capital Management sold 88,358 CareDx shares in Q3 2021, an estimated $8.09M.
  • Penserra Capital Management first reported a position in CareDx in Q2 2021 and held it in 1 quarter.
  • Penserra Capital Management's CareDx position peaked at $8.09M in Q2 2021.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.